Video & Transcript Research : 'prescriptive authority'

Page 46 of 500
MN

Minnesota 2025-2026 Regular Session

Cap Committee Meeting - 2026-04-16

Capital Investment

Transcript Highlights:
  • Senator Johnson for helping author Senator Johnson for helping author bills,<00:21:33.440> including
  • My name is Chris McConn, executive director of the Prairie Lakes Municipal Solid Waste Authority.
  • Authorized by the MPCA to use combustor ash in road construction materials.
  • <00:44:55.200> The or the public facilities authority.
  • The or the public facilities authority.
OK

Oklahoma 2026 Regular Session

Commerce and Economic Development Oversight Apr 14th, 2026 at 03:00 pm

Commerce & Economic Development Oversight

Transcript Highlights:
  • Authority. Having a due pass, then. Will there be discussion or debate? Chair sees none.
  • Members, this just gives back the authority, the full authority, to the Oklahoma Tourism and Recreation
  • Board to have full authority over that agency.
  • And this would just give them more authority over tourism and recreation.
  • This would just give them more authority over tourism and recreation.
OK

Oklahoma 2026 Regular Session

Judiciary Apr 14th, 2026 at 01:30 pm

Judiciary

Transcript Highlights:
  • Will there be questions of the author? What is the will of the committee?
  • Senator Brooks, you're recognized for a question to the author. Thank you.
  • The author waves. Clerk, will call the roll. Senator Boren.
  • Seeing no debate, as the author wishes to close. The author waives. Clerk, will call the roll.
  • Does the author wish to debate? The author waives. Clerk, coloro.
OK

Oklahoma 2026 Regular Session

Aeronautics and Transportation REVISED Apr 13th, 2026 at 10:00 am

Aeronautics and Transportation

Transcript Highlights:
  • It will be questions of the author, questions of Goodwin.
  • Questions of the author, questions of Senator Stewart.
  • I just want to commend the author for bringing this bill.
  • The questions of the author. I did have a question, senator.
  • It questions of the author, questions of the author Saying no questions.
AZ

Arizona 2026 Regular Session

03/16/2026 - House Health & Human Services

Health & Human Services

Transcript Highlights:
  • In terms of speed right now, behavioral health fee-for-service prior authorization turnaround time is
  • Expansion of IV antimicrobial authority without access to a strong stewardship program in a hospital
  • And let's be clear, 1178 does not expand prescribing authority. I think we've made that clear.
  • Naturopathic physicians are already authorized by law to prescribe antibiotics and antivirals.
  • The bill complies with federal Medicaid standards and does not restrict enforcement authority.
Summary: The committee first heard Senate Bill 1114, which would appropriate $1 million to the Maricopa County Attorney’s Office to investigate behavioral health patient brokering statewide. Sponsor Sen. Karen Werner described the bill as a response to fraud involving vulnerable Native Americans and said the county attorney would investigate the whole state. Some members questioned why the Attorney General was not handling the work and whether the funding should go to a county office, while others supported the effort. The committee voted 10-1 with one present to give SB 1114 a due pass recommendation. The committee then considered Senate Bill 1116, which would require that denials or adverse appeal decisions on behavioral health claims for the American Indian Health Program be reviewed by someone with at least two years of relevant clinical experience. Access testified neutral but said the bill’s language was too broad and could increase appeals and staffing needs, estimating about $490,000 for eight FTEs. Sen. Werner said the bill was meant to prevent inappropriate denials by reviewers without relevant expertise. Members raised concerns about definitions and staffing, and the committee approved the bill 7-4 with one present. Senate Bill 1346 would require Access to notify providers of claim deficiencies within 72 hours and decide corrected claims within 10 business days. Supporters said the measure would reduce long delays and help providers stay afloat; Access said it was working on process improvements but warned the bill would require more staff and system changes, estimating about $580,000. The committee passed SB 1346 7-5. Senate Bill 1347, requiring insurance coverage for fertility preservation services for cancer patients at risk of infertility, drew strong support from cancer survivors and advocates, with insurers neutral; the committee passed it unanimously 12-0. The committee also heard Senate Bill 1813, which would require Arizona State Hospital admissions to be based on clinical need rather than county of residence. Supporters argued the Maricopa County cap unfairly delays treatment and is not required by the underlying court ruling, while ADHS warned the bill could conflict with the Arnold v. Sarn settlement and could shift access away from rural counties. After extensive discussion, the committee passed SB 1813 9-2 with one present. Finally, the committee began hearing Senate Bill 1178, which would allow naturopathic physicians to administer IV antibiotics, antivirals, and antifungals; the initial testimony was largely opposed by medical associations on patient-safety and training grounds, with supporters yet to testify in the excerpt provided.
NM

New Mexico 2026 Regular Session

Senate - Tax, Business and Transportation Feb 5th, 2026 at 04:18 pm

Senate Tax, Business & Transportation

Transcript Highlights:
  • What this bill does is authorize the New Mexico Finance Authority to issue revenue bonds to support capital
  • The bonds are repaid using existing tobacco tax revenues already authorized in state statute.
  • The bonds are repaid using existing tobacco tax revenues already authorized in state statute.
  • The New Mexico Finance Authority has a long track record of prudent bond issuance and oversight.
  • We've had numerous conversations with the New Mexico Finance Authority about how this works and making
OK

Oklahoma 2026 Regular Session

Business and Insurance REVISED Feb 5th, 2026 at 09:30 am

Business and Insurance

Transcript Highlights:
  • Will there be questions of the author on the bill? Seeing none, will there be debate?
  • Will there be questions of the author? Seeing none, will there be debate?
  • The big questions of the author on the bill to pass from Senator Brooks.
  • Will there be questions of the author on the bill? Seeing none, will there be debate?
TX

Texas 89th Regular

Press Conference: Senator Nathan Johnson Jul 30th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Another important thing to remember is all that we have with even the author of SB5.
  • can't have TCUP if we have a regulated THC market is about—like I say, we can't have Advil and prescription
Bills: SB5, SB11, SB12, SB9, SB42, SB15, SB5, SB11, SB12, SCR1
TX

Texas 89th Regular

Senate Session (Part II) Jul 30th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Question of the author. Do you yield? Of course I'll yield, Mr. President.
  • This bill, if passed... gives the Attorney General authority to prosecute.
  • and such other authority as the legislature shall prescribe.
  • prosecutorial authorities, of. a district or county attorney?
  • Members, any other questions for the author, Senator Hughes?
Bills: SB5, SB11, SB12, SB9, SB42, SB15, SB5, SB11, SB12, SCR1
TX

Texas 89th Regular

Senate Session (Part I) Jul 30th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Questions of the author? Do you yield? I yield. Thank you Mr. President. Thank you Senator Perry.
  • Questions for the author? Do you yield? I yield. Thank you, Mr. President.
  • I honestly think we can coming from the author and architect of the statewide water plan.
  • To ask questions of the author, if I might. Do you yield? Do you yield, Senator Perry?
  • I still question the ruling, but they do have the authority to go in and out of control once.
Bills: SB5, SB11, SB12, SB9, SB42, SB15, SB5, SB11, SB12, SCR1
TX
Transcript Highlights:
  • These sales often occur in high-traffic, unincorporated areas where counties currently lack legal authority
  • This authority currently applies to Hidalgo County, Cameron County, El Paso County, and Webb County.
  • It also includes county authority to regulate other types of roadside vendors like food and merchandise
  • The committee narrows the bill's scope by limiting regulatory authority to live animal vendors. ...only
  • expanded the authority of the hospital district.
MN

Minnesota 2025-2026 Regular Session

House Capital Investment Committee 4/30/25

Capital Investment

Transcript Highlights:
  • are able to turn it back to the county, and then if you get commitments from each of those taxing authorities
  • 00:26:39.039> of<00:26:39.200> those<00:26:39.440> taxing<00:26:39.919> authorities
  • from each of those taxing authorities from each of those taxing authorities you<00:26:40.799>
TX

Texas 89th Regular

S/C on Disease Prevention & Women's & Children's Health Apr 17th, 2025

S/C on Disease Prevention & Women's & Children's Health

Transcript Highlights:
  • The way we envision trying to communicate with HHSC when they develop those prior authorization criteria
  • kind of, you know, there's something new that could be good, and as an agency do y'all have the authority
  • It's through the local mental health authorities. All right, you probably said that.
  • So it's through the local mental health authority.
  • I'm a joint author and co-author of a number of those bills.
MN

Minnesota 2025-2026 Regular Session

House Capital Investment Committee 3/20/25

Capital Investment

Transcript Highlights:
  • I want to express my Authority.
  • And the executive director of the Flood Diversion Authority is also in my office.
  • Um, and they have to be authorized by three-fifths of both chambers of the legislature.
  • Um, and they have to be authorized by three-fifths of both chambers of the legislature.
  • They don't require the three-fifths authorization requirement.
TX
Transcript Highlights:
  • Any questions of the author? Hearing none, let me substitute Senate Bill 504. Adopted.
  • This bill is about utilization of AI now in reference to prior authorization.
  • medical devices unless they are legally authorized and licensed to perform these acts.
  • But authority over the estheticians is unclear in both TMB and TDR statutes.
  • Members, any questions for the bill author?
MN

Minnesota 2025 1st Special Session

House Capital Investment Committee 3/6/25

Capital Investment

Transcript Highlights:
  • cities that do not pertain to the actual language of the bill at hand, I ask that you talk to the bill author
  • cities that do not pertain to the actual language of the bill at hand, I ask that you talk to the bill author
  • in June of 23 the project is Authority in June of 23 the project is currently<00:37:14.440> on
  • The city has applied for the Public Facilities Authority PPL and the IUP for this project.
  • applied for public facility Authority applied for public facility Authority and<01:17:42.159>
KY
Transcript Highlights:
  • Did Medicaid pay for any prescription Did Medicaid pay for any prescription drug<00:05:59.600>
  • > weight diabetes and prescriptions for weight diabetes and prescriptions for weight loss.<00:10:
  • <00:10:31.120> loss prescriptions approved for weight loss prescriptions approved for weight
  • prescription was $975. prescription was $975.
  • prescription is $109. prescription is $109.
Keywords: 958, all
Summary: The Medicaid Oversight and Advisory Board met on February 23, 2026, approved the January 12 minutes, and then focused primarily on Kentucky Medicaid’s coverage and potential expansion of GLP-1 drugs, especially for weight loss. Department for Medicaid Services Commissioner Lisa Lee explained that Medicaid currently does not cover drugs for weight loss, anorexia, or weight gain, but the department had filed a regulation to remove that blanket exclusion so GLP-1s could be covered when used for an underlying health condition. She said the administrative regulation review subcommittee found the regulation deficient, and the co-chairs wanted the board to discuss the policy and financing implications before any change. DMS also said it would be open to adding caveats to ensure coverage would not extend to cosmetic weight loss alone. The department provided several data points on current utilization and spending. In 2025, Kentucky Medicaid paid for appetite-stimulating drugs such as Megestrol, Dronabinol, and Marinol, but did not pay for weight-loss drugs. For GLP-1s, DMS said coverage began in 2025 and is limited to FDA-approved medical conditions, with prior authorization requiring a type 2 diabetes diagnosis code and A1C documentation. DMS reported $234.6 million in GLP-1 spending in 2025 before rebates, about 240,931 prescriptions, and said GLP-1s accounted for 7.3% of pharmacy spend in 2024 and 8.3% in 2025. It also said there were 24,844 expansion members and 13,638 non-expansion members using GLP-1s, with spending of about $156 million and $78.5 million respectively, and that 10 pediatric weight-loss prescriptions were covered under EPSDT. The department said outcome analyses, including whether GLP-1 use reduces insulin or other diabetes treatment, are underway and should be completed in a couple of months. Members asked about cost, rebates, and whether the state should wait for more outcomes data before expanding coverage. DMS said average reimbursement to pharmacies was $975 per prescription and the average dispensing fee was $109; it also said 2025 rebate invoices totaled $90.8 million, with $7.6 million collected so far. Several members expressed concern about the high cost and the need to evaluate whether the drugs improve health outcomes before expanding access, while others noted the potential benefits for obesity and diabetes treatment. Some members also discussed whether GLP-1s are effectively being used for weight loss in diabetic patients and whether broader data collection should be used to assess long-term value. After the Medicaid discussion, Eli Lilly executive Tracy Sims presented on obesity as a chronic disease and the economic burden it creates in Kentucky. She said Kentucky’s adult obesity rate is a little over 37%, that obesity is linked to about 200 diseases, and that untreated obesity costs the state billions in GDP and hundreds of millions in state budget impact. She highlighted recent federal access programs for GLP-1s, including a Medicaid-related program that she said could lower the state share of a Zepbound prescription to about $71 per month after federal matching. No votes were taken on the GLP-1 policy question during the meeting, and the main action was the receipt of testimony and discussion of the department’s proposed regulatory change.